Luo, Y., Paul, S. K., Zhou, X., Chang, C., Chen, W., Guo, X., . . . Wang, H. (2017). Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention and/or Pioglitazone in Reversion to Normal Glucose Tolerance in Prediabetes. J Diabetes Res.

Luo, Yingying, Sanjoy K. Paul, Xianghai Zhou, Cuiqing Chang, Wei Chen, Xiaohui Guo, Jinkui Yang, Linong Ji, e Hongyuan Wang. "Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention And/or Pioglitazone in Reversion to Normal Glucose Tolerance in Prediabetes." J Diabetes Res 2017.

Luo, Yingying, et al. "Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention And/or Pioglitazone in Reversion to Normal Glucose Tolerance in Prediabetes." J Diabetes Res 2017.